Table 2.
Study cohort vascular measurements.
| Number | Mean (SD) | ||
|---|---|---|---|
| SBP, mmHg | 22 | 120 | (11) |
| PWA, augmentation index at 75 bpm | 22 | 17 | (13) |
| PWV, m/s | 21 | 7.5 | (1.1) |
| RHI, % | 20 | 2.1 | (0.7) |
| CIMT, mm | 21 | 0.64 | (0.1) |
| FMD, % | 18 | 4.1 | (1.9) |
| MFV, cm/s | 21 | 40 | (9.5) |
| Brain parenchyma CBF, ml/100 g/min | 19 | 46 | (8.6) |
| Grey matter CBF, ml/100 g/min | 19 | 51 | (9.4) |
| White matter CBF, ml/100 g/min | 19 | 43 | (7.6) |
| Subcortical hyperintensity CBF, ml/100 g/min | 19 | 30 | (5.6) |
| CVRTCD, % | 21 | 19 | (11.2) |
| Grey matter CVRASL, % | 13 | 9.5 | (9.3) |
| Subcortical hyperintensity CVRASL, % | 13 | 9.0 | (7.7) |
SBP: systolic blood pressure; BMI: body mass index; PWA: pulse wave analysis; PWV: pulse wave velocity; RHI: reactive hyperaemia index; CIMT: carotid intima-media thickness; FMD: flow mediated dilatation; MFV: mean flow velocity; CBF: cerebral blood flow.